Associated Papers
Novel Germline KIT Variants in Families With Severe Piebaldism: Case Series and Literature Review.
Zhang Y et al.
Journal of Clinical Laboratory Analysis, 2024
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix.
Takayanagi D et al.
Cancers, 2021
33802174 (PubMed )
Supplement: cancers-13-01215-s001.zip › Supplymentary_files › Supplymental_table.xlsx › TableS1
KIT-related piebaldism in a Chinese girl.
Zhu L et al.
American Journal of Medical Genetics. Part A, 2020
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.
de Unamuno Bustos B et al.
Scientific Reports, 2017
28356599 (PubMed )
Supplement: 41598_2017_606_MOESM2_ESM.xls › Table_S1
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F et al.
Oncotarget, 2016
Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.
Xiu J et al.
Oncotarget, 2016
Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
Swick BL et al.
Journal of Cutaneous Pathology, 2013
The energy landscape analysis of cancer mutations in protein kinases.
Dixit A et al.
Plos One, 2011
21998754 (PubMed )
Supplement: pone.0026071.s009.doc
Exploring the cause of drug resistance by the detrimental missense mutations in KIT receptor: computational approach.
Rajasekaran R et al.
Amino Acids, 2010
Recent advances in the understanding of mastocytosis: the role of KIT mutations.
Orfao A et al.
British Journal of Haematology, 2007
Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I.
Orlova KV et al.
Case Reports in Oncology, 0
31043947 (PubMed )
Supplement: cro-0012-0109-s01.pdf
Select a paper to view details